Thomas R. Cannell serves as Executive at Orexigen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Thomas R. Cannell has executed 9 insider transactions totaling $319.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 2, 2023 involved selling 278,564 shares valued at $164.4K.
Thomas R. Cannell currently holds 672,386 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas R. Cannell has been a net seller of OREX stock. They have purchased $0 and sold $319.3K worth of shares.
Thomas R. Cannell's most recent insider trade was on Mar 2, 2023, when they sold 278,564 shares at $0.59 per share.
Get notified when new Form 4 filings are submitted
| $0.59 |
| Discretionary |
| Mar 2, 2023 | SESN | $358.0K | Option Exercise | 606,800 | $0.59 | Discretionary |
| Feb 21, 2023 | SESN | $31.7K | Sale | 53,727 | $0.59 | Discretionary |
| Feb 18, 2022 | SESN | $0 | Award | 606,800 | $N/A | Discretionary |
| May 31, 2017 | OREX | $3.3K | Award | 2,119 | $1.55 | Discretionary |
| Nov 30, 2016 | OREX | $486 | Award | 291 | $1.67 | Discretionary |
| May 31, 2016 | OREX | $3.3K | Award | 9,632 | $0.34 | Discretionary |
| Nov 30, 2015 | OREX | $10.3K | Award | 5,091 | $2.03 | Discretionary |